Skip to content
Patch Next
Sign inAdd to your agent

← Actionable
High, CVSS 7.5amended

Directory Traversal in xtalk

CVE-2017-16091GHSA-cqv6-7fwc-8m3c

What to do

Vendor response not established. Follow the primary source's mitigation guidance and check back for a fix.

This page has no inventory attached, so it cannot say whether you are affected. A vendor fix is not proof that your deployment is fixed.

Add to your agent

Affected packages

  • npm xtalk

    Affected
    >= 0.0.2
    Fixed in
    no fixed version recorded

Sources

Severity and exploitation
Exploitation
No confirmed exploitation recorded. Patch Next marks exploitation only from CISA KEV.
CVSS
7.5 · CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N
EPSS
  • CVE-2017-16091: 1.77% estimated exploitation activity in the next 30 days; percentile 78.10 (FIRST EPSS, 2026-11-03). This is a model estimate, not proof of exploitation or customer exposure.
Source description

As published by the source; long descriptions are shortened.

Affected versions of xtalk are vulnerable to directory traversal, allowing access to the filesystem by placing "../" in the URL. Example request: Recommendation No patch is currently available for this vulnerability, and the package has not been updated since 2014. The best mitigation is currently to avoid using this package, and using a different, functionally equivalent package.

Dates and revisions
Published by the source
Last modified by the source
Source last checked
  1. Revision 2 · amended ·

    Amended from ghsa record GHSA-cqv6-7fwc-8m3c

  2. Revision 1 · created ·

    Published from osv record GHSA-cqv6-7fwc-8m3c

Agent brief

Preview the exact text before you copy it. Commands are read-only suggestions; review them before running anything.

# Patch Next advisory brief: CVE-2017-16091

Advisory: Directory Traversal in xtalk
IDs: CVE-2017-16091, GHSA-cqv6-7fwc-8m3c
Record: https://patchnext.com/advisories/cve-2017-16091 (revision 2, source checked 26 Oct 2026, 12:26 UTC)
Inventory: none attached. This brief comes from a public page and does not say whether any deployment is affected.
Severity: High (CVSS 7.5)
Exploitation: no confirmed exploitation recorded. Patch Next confirms exploitation only from CISA KEV.
Vendor response: Vendor response not established. A vendor fix does not mean a deployment is fixed.

## Affected components
- npm xtalk: affected >= 0.0.2

## Suggested inspection (read-only)
- `npm ls xtalk --all`: lists every installed copy and version, including transitive ones. Run in the project root after `npm ci`.

## Supported action
No complete vendor fix is recorded. Follow the primary source's mitigation guidance and check this record again before closing anything.

## Required regression checks
- Run the test suite and a production build.
- Exercise the features that depend on xtalk.
- Repeat the inspection and confirm that only fixed versions remain installed.

## Rollback considerations
- Keep the previous lockfile and deployment artifact. Rolling back reinstates the vulnerable version, so apply any documented mitigation while you fix forward.

## Unresolved questions
- Which deployments run an affected version?
- Exploitation status can change. Check again before lowering the priority.
- Mark the work resolved only after the fixed version is verified in production.

## Sources
- Verified: https://osv.dev/vulnerability/GHSA-cqv6-7fwc-8m3c (OSV record GHSA-cqv6-7fwc-8m3c lists affected ranges: npm xtalk >=0.0.2)
- Verified: https://github.com/advisories/GHSA-cqv6-7fwc-8m3c (GitHub-reviewed advisory GHSA-cqv6-7fwc-8m3c lists affected ranges: npm xtalk >=0.0.2)

Commands are suggestions: review each one before running it.

Loading voting…